Pharmacelsus' Grant

Pharmacelsus raised a round of funding on June 30, 2016. Investors include Eurostars Programme.

Pharmacelsus is a preclinical contract research organization. Pharmacelsus' service portfolio comprises the complete drug discovery and development testing program (in vitro, in vivo, ex vivo) as well…

Articles about Pharmacelsus' Grant: